Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

COMPASS Pathways plc (CMPS) Cash Flow Statement

COMPASS Pathways plc (CMPS) generated -$161.1M of operating cash flow over the twelve months to 2026-06-30, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CMPSCOMPASS Pathways plcFollow CMPS — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
1.5B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
2 Nov, in 9 days
LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-41.4-67.7-105.5-97.4-119.2-157.2-161.1
Capital expenditure0.10.30.60.10.0——
Free cash flow-41.5-68.1-106.0-97.4-119.2——
Dividends paid—————0.0—
Stock-based compensation18.08.613.117.319.513.6—

USD millions · SEC XBRL

COMPASS Pathways plc — questions

What is COMPASS Pathways plc's operating cash flow?
-$161.1M over the twelve months to 2026-06-30.

Every figure on this page comes from COMPASS Pathways plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.